These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
119 related items for PubMed ID: 17435838
21. Anti-MCV antibodies predict radiographic progression in Greek patients with very early (<3 months duration) rheumatoid arthritis. Barouta G, Katsiari CG, Alexiou I, Liaskos C, Varna A, Bogdanos DP, Germenis AE, Sakkas LI. Clin Rheumatol; 2017 Apr; 36(4):885-894. PubMed ID: 27943044 [Abstract] [Full Text] [Related]
22. Diagnostic value of anti-cyclic citrullinated peptide antibodies in Greek patients with rheumatoid arthritis. Alexiou I, Germenis A, Ziogas A, Theodoridou K, Sakkas LI. BMC Musculoskelet Disord; 2007 Apr 20; 8():37. PubMed ID: 17448247 [Abstract] [Full Text] [Related]
24. Anti-CCP and antikeratin antibodies in rheumatoid arthritis, primary Sjögren's syndrome, and Wegener's granulomatosis. Kamali S, Polat NG, Kasapoglu E, Gul A, Ocal L, Aral O, Konice M, Badur S, Inanc M. Clin Rheumatol; 2005 Nov 20; 24(6):673-6. PubMed ID: 15926038 [Abstract] [Full Text] [Related]
27. Determination of anti-cyclic citrullinated peptide antibodies in the sera of patients with juvenile idiopathic arthritis. Low JM, Chauhan AK, Kietz DA, Daud U, Pepmueller PH, Moore TL. J Rheumatol; 2004 Sep 20; 31(9):1829-33. PubMed ID: 15338508 [Abstract] [Full Text] [Related]
28. [Anti-cyclic citrullinated peptide antibodies and rheumatoid arthritis]. Hayashi N, Kumagai S. Rinsho Byori; 2010 May 20; 58(5):466-79. PubMed ID: 20560456 [Abstract] [Full Text] [Related]
31. Autoantibody profiling as early diagnostic and prognostic tool for rheumatoid arthritis. Nell VP, Machold KP, Stamm TA, Eberl G, Heinzl H, Uffmann M, Smolen JS, Steiner G. Ann Rheum Dis; 2005 Dec 20; 64(12):1731-6. PubMed ID: 15878904 [Abstract] [Full Text] [Related]
32. [Cyclic citrullinated peptide antibodies (anti-CCP) together with some other parameters used for serologic diagnosis of rheumatoid arthritis]. Us D, Gülmez D, Hasçelik G. Mikrobiyol Bul; 2003 Dec 20; 37(2-3):163-70. PubMed ID: 14593899 [Abstract] [Full Text] [Related]
34. The clinical significance of antibody determination to cyclic citrullinated peptides in systemic sclerosis. Stamenković B, Stanković A, Dimić A, Damjanov N, Nedović J, Stojanović S, Savić V, Djordjević D. Srp Arh Celok Lek; 2012 Dec 20; 140(5-6):350-4. PubMed ID: 22826990 [Abstract] [Full Text] [Related]
36. Role of anti cyclic citrullinated peptide antibodies in erosive disease in patients with rheumatoid arthritis. Shankar S, Grover R, Handa R. Indian J Med Res; 2006 Dec 20; 124(6):689-96. PubMed ID: 17287557 [Abstract] [Full Text] [Related]
37. Anti-carbamylated protein antibodies are present in arthralgia patients and predict the development of rheumatoid arthritis. Shi J, van de Stadt LA, Levarht EW, Huizinga TW, Toes RE, Trouw LA, van Schaardenburg D. Arthritis Rheum; 2013 Apr 20; 65(4):911-5. PubMed ID: 23279976 [Abstract] [Full Text] [Related]
38. Association of anti-cyclic citrullinated peptide antibodies, anti-citrullin antibodies, and IgM and IgA rheumatoid factors with serological parameters of disease activity in rheumatoid arthritis. Greiner A, Plischke H, Kellner H, Gruber R. Ann N Y Acad Sci; 2005 Jun 20; 1050():295-303. PubMed ID: 16014545 [Abstract] [Full Text] [Related]
40. [A comparative evaluation of the diagnostic value of anti-cyclic citrullinated peptide and rheumatoid factor in rheumatoid arthritis]. Cho SY, Kang SY, Lee HJ, Lee WI. Korean J Lab Med; 2008 Feb 20; 28(1):39-45. PubMed ID: 18309254 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]